The emerging treatment of the medication represents a exciting development in the care of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – providing greater glucose https://tirzepatidepeptide171314.nizarblog.com/42361609/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment